These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6950026)

  • 1. Host factors and susceptibility to rubella virus infection: the association of HLA antigens.
    Ishii K; Nakazono N; Sawada H; Fukuda K; Wakisaka A; Moriuchi J; Nakai Y; Kano T; Aizawa M
    J Med Virol; 1981; 7(4):287-97. PubMed ID: 6950026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens and responses to rubella vaccination.
    Harcourt GC; Best JM; Banatvala JE; Kennedy LA
    J Hyg (Lond); 1979 Dec; 83(3):405-12. PubMed ID: 512353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR antigens and the rubella-specific immune response in man.
    Kato S; Muranaka S; Takakura I; Kimura M; Tsuji K
    Tissue Antigens; 1982 Feb; 19(2):140-5. PubMed ID: 6808699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and the rubella-specific immune response following vaccination.
    Van Eden W; UytdeHaag F; Loggen HG; Plantinga AD; De Vries RR; Van Rood JJ
    Exp Clin Immunogenet; 1984; 1(2):70-4. PubMed ID: 6400993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens and antibody responses to measles and rubella viruses in multiple sclerosis.
    Ilonen J; Herva E; Reunanen M; Panelius M; Meurman O; Arstila P; Tiilikainen A
    Acta Neurol Scand; 1977 Apr; 55(4):299-309. PubMed ID: 855642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens in rubella seronegative young adults.
    Ilonen J; Anttila AC; Lehtinen M; Hakkarainen K; Pietiläinen M; Tiilikainen A; Leinikki P
    Tissue Antigens; 1983 Nov; 22(5):379-82. PubMed ID: 6362071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubella immunity: comparison of hemagglutination inhibition and radioimmunoassay antibody methods.
    Harris RE; Smith KO; Gehle WD; Dupuy HJ
    Obstet Gynecol; 1980 May; 55(5):603-7. PubMed ID: 7366918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rubella HI antibody titer prior to and after the epidemic in the same group and other viral infection in rubella epidemic (author's transl)].
    Watanabe N
    Kansenshogaku Zasshi; 1979 Mar; 53(3):115-20. PubMed ID: 112196
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors associated with clinical reactions to rubella vaccination in women.
    Nakazono N; Fujimoto S; Wakisaka A; Ishii K; Ichinoe K; Aizawa M
    Int J Gynaecol Obstet; 1987 Jun; 25(3):207-16. PubMed ID: 2886379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serosurveillance of susceptibility to rubella in a Mexican female group.
    Montero MT; Varela Y; Gid G; Namihira D; Gómez B
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):49-54. PubMed ID: 1619293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
    Hillary IB; Freestone DS
    J Hyg (Lond); 1975 Dec; 75(3):407-11. PubMed ID: 1059708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between the incidence of rubella antibody and the distribution of HLA antigens in a Danish population.
    Hansen HE; Larsen SO; Leerhøy J
    Tissue Antigens; 1980 Mar; 15(3):325-8. PubMed ID: 7466774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination.
    Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
    Hum Immunol; 2004 Dec; 65(12):1506-15. PubMed ID: 15603879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
    Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
    Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response following rubella immunization analyzed by HLA types.
    Ishii K; Nakazono N; Sawada H; Wakisaka A; Moriuchi J; Nakai Y; Kano T; Aizawa M
    Jpn J Med Sci Biol; 1980 Apr; 33(2):103. PubMed ID: 7412020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-linked genetic control in natural rubella infection.
    Kato S; Kimura M; Takakura I; Tsuji K; Ueda K
    Tissue Antigens; 1980 Jan; 15(1):86-9. PubMed ID: 12735338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low level rubella immunity detected by ELISA and specific lymphocyte transformation.
    Buimovici-Klein E; O'Beirne AJ; Millian SJ; Cooper LZ
    Arch Virol; 1980; 66(4):321-7. PubMed ID: 7447708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella in Umbria (Italy): serological assessment of immunity in adult women and congenital rubella detection after 1978.
    Iorio AM; Greco M; Trabalza N; Cappuccini B; Barboni G; Perocchi F
    Boll Ist Sieroter Milan; 1981; 60(4):278-83. PubMed ID: 7326102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.